Providers Coverage Costs Reference

23/51 states verified · 14/25 providers audited

Medicaid coverage

Delaware: what Medicaid covers

Delaware runs an obesity treatment agents class where every agent needs prior authorization. Two preferred products have to be tried before a non-preferred one is approved, which puts Saxenda and the Wegovy tablet behind the Wegovy and Zepbound pens.

Checked against the primary source August 25, 2026
What Medicaid in Delaware covers, and the criteria that apply.
Drug Position Criteria
Semaglutide Prior authorization Wegovy pen and Wegovy HD preferred. Wegovy tablets non-preferred. Prior authorization on every agent in the class
Tirzepatide Prior authorization Zepbound auto-injector and KwikPen both preferred. Prior authorization on every agent in the class
Liraglutide Prior authorization Saxenda and the generic pen are non-preferred, so two preferred products have to be tried first
If the answer is no. Around 45% of initial prior authorizations for these drugs are refused, and 35 to 45% of first-level appeals are overturned. A refusal is not the end of the process, and the cash-pay routes are priced on this site alongside it.

Sources

Every claim above is checked against the primary text, and the date is the day we last opened it.

  1. 1
    2026 Delaware Medicaid Preferred Drug List

    Delaware Division of Medicaid and Medical Assistance Primary text read and checked Checked August 25, 2026